Abstract
Gene therapy approaches to the treatment of experimental cancer are usually based on established neoplastic cell lines which are manipulated in vitro and subsequently transplanted in host animals. However, the relevance of these artificial models to the biology and therapy of human tumors is uncertain. We have previously validated an experimental model based on MMTV-neu transgenic mice in which breast tumors arise spontaneously in 100% of animals and have many features in common with their human counterpart, including the involvement of the neu oncogene and the ability to metastatize. In this article we report the effect of intratumoral, retrovirus-mediated, IL-4 expression on the growth of breast tumors arising in these mice. The size of IL-4 inoculated tumors on the right side was significantly smaller than that of controlateral untreated tumors, suggesting a local effect of IL-4. In addition, the non-injected tumors on the left side of treated animals were significantly smaller than those arising in control transgenic mice, suggesting that IL-4 can also inhibit tumor growth systemically. These findings suggest that IL-4 gene transfer can significantly reduce the growth rate of spontaneously arising breast tumors and that immune-based gene therapy could efficiently complement other approaches based on different mechanisms, such as suicide gene transfer or antisense technology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hanahan D . Transgenic mice as probes into complex systems Science 1989 246: 1265–1275
Pattengale PK et al. Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes Am J Pathol 1989 135: 39–61
Jacks T . Tumor suppressor gene mutations in mice Annu Rev Genet 1996 30: 603–636
Sacco MG et al. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retrovirus-mediated HSVtk transfer in vivo Gene Therapy 1996 3: 1151–1156
Sacco MG et al. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice Gene Therapy 1998 5: 388–393
Sacco MG et al. Local regression of breast tumors following intrammary ganciclovir administration in double transgenic mice expressing neu oncogene and herpes simplex virus thymidine kinase Gene Therapy 1995 2: 493–497
Sacco MG et al. Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice Breast Cancer Res Treat 1998 47: 171–180
Lucchin F et al. Early and multifocal tumors in breast, salivary, harderian and epididimal tissues developed in MMTV-Neu transgenic mice Cancer Lett 1992 64: 203–209
Boggio K et al. Interleukin-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/Neu transgenic mice J Exp Med 1998 188: 589–596
Rogulski KR, Kim JH, Kim SH, Freytag SO . Glioma cells transduced with an E. coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity Hum Gene Ther 1997 8: 73–85
Heise C et al. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolisis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents Nature Med 1997 3: 639–645
Freytag SO et al. A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene and radiotherapy Hum Gene Ther 1998 9: 1323–1333
Tepper RI, Pattengale PK, Leder P . Murine interleukin-4 displays potent anti-tumor activity in vivo Cell 1989 57: 503–512
Hoon DSB et al. Modulation of human melanoma cells by interleukin 4 and in combination with γ-interferon or α-tumor necrosis factor Cancer Res 1991 51: 2002–2008
Morisaki T et al. Interleukin 4 regulates G1 cell cycle progression in gastric carcinoma cells Cancer Res 1994 54: 1113–1118
Topp MS et al. Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies Cancer Res 1995 55: 2173–2176
Toi M, Bicknell R, Harris AL . Inibition of colon and breast carcinoma cell growth by interleukin 4 Cancer Res 1992 52: 275–279
Blais Y et al. Interleukin 4 and interleukin 13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells Mol Cell Endocrinol 1996 121: 11–18
Gooch JL, Lee AV, Yee D . Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells Cancer Res 1998 58: 4199–4205
Paillard F . Cancer cells under the fire of combined therapies Hum Gene Ther 1998 9: 1259–1260
Paul WE . Interleukin-4: a prototypic immunoregulatory lymphokine Blood 1991 77: 1859–1870
Colombo MP, Modesti A, Parmiani G, Forni G . Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T lymphocyte cross-talk Cancer Res 1992 52: 4853–4857
Pericle F et al. An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4 J Immunol 1994 153: 5659–5673
Volpert O et al. Inhibition of angiogenesis by interleukin 4 J Exp Med 1998 188: 1039–1046
Colombo BM et al. The ‘bystander effect’: association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice Hum Gene Ther 1995 6: 763–772
Acknowledgements
The technical assistance of Dario Strina, Angela Pettinicchio and Remo Di Bacco is acknowledged. We thank Prof R Dulbecco for encouragement and Ms Victoria Starnes for typing the manuscript. The financial support of AIRC to AV is gratefully acknowledged. This is manuscript No. 28 of the Genoma 2000/ITBA Project funded by CARIPLO. SB is supported by a fellowship from AIRC.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sacco, M., Benedetti, S., Catò, E. et al. Retrovirus-mediated IL-4 gene therapy in spontaneous adenocarcinomas from MMTV-neu transgenic mice. Gene Ther 6, 1893–1897 (1999). https://doi.org/10.1038/sj.gt.3301017
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301017
Keywords
This article is cited by
-
Combined antiestrogen, antiangiogenic and anti-invasion therapy inhibits primary and metastatic tumor growth in the MMTVneu model of breast cancer
Gene Therapy (2003)
-
Combined effects on tumor growth and metastasis by anti-estrogenic and antiangiogenic therapies in MMTV-neu mice
Gene Therapy (2002)
-
Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice
Gene Therapy (2001)